Kala Pharmaceuticals CEO Mark Iwicki's 2018 pay jumps 65% to $3.1M
Kala Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 12, 2019
Kala Pharmaceuticals reported fiscal year 2018 executive compensation information on April 12, 2019.
In 2018, three executives at Kala Pharmaceuticals received on average a compensation package of $2.3M, a 49% increase compared to previous year.
Average pay of disclosed executives at Kala Pharmaceuticals
Mark Iwicki, Chief Executive Officer, received $3.1M in total, which increased by 65% compared to 2017. 70% of Iwicki's compensation, or $2.1M, was in option awards. Iwicki also received $385K in bonus, $535K in salary, as well as $7.7K in other compensation.
Eric L. Trachtenberg, General Counsel, received a compensation package of $2.4M. 75% of the compensation package, or $1.8M, was in option awards.
Kim Brazzell, Chief Medical Officer, earned $1.3M in 2018, a 10% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 12, 2019.